"SARS-CoV-2" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonA biosafe mouse model for SARS-CoV-2 infection that more realistically simulates COVID-19 symptom...
A biosafe mouse model for SARS-CoV-2 infection that more realistically simulates COVID-19 symptoms Nature
COVID-19-Associated Cardiovascular Complications: A Narrative Literature Review - Cureus
COVID-19-Associated Cardiovascular Complications: A Narrative Literature Review Cureus
Natural Fungal Supplement Improved COVID-19 Vaccine Response - respiratory-therapy.com
Natural Fungal Supplement Improved COVID-19 Vaccine Response respiratory-therapy.com
High-Dose Vitamin D3 Does Not Reduce Acute COVID-19 Severity, But May Hold Promise for Long COVID...
High-Dose Vitamin D3 Does Not Reduce Acute COVID-19 Severity, But May Hold Promise for Long COVID Pharmacy Times
National COVID-19 trends, March 17 - The Sick Times
National COVID-19 trends, March 17 The Sick Times
VDH: COVID low, no measles, flu and RSV still high - Vermont Business Magazine
VDH: COVID low, no measles, flu and RSV still high Vermont Business Magazine
Nature Comms Med.: Interactions of SARS-CoV-2, Influenza and RSV Influence Epidemic Timing and Ri...
Nature Comms Med.: Interactions of SARS-CoV-2, Influenza and RSV Influence Epidemic Timing and Risk Avian Flu Diary
Recent pandemic viruses, including SAR-CoV-2, spread directly to people without adaptation, resea...
COVID-19 Treatment Clinical Care for Outpatients - Centers for Disease Control and Prevention | C...
COVID-19 Treatment Clinical Care for Outpatients Centers for Disease Control and Prevention | CDC (.gov)
Acetylsalicylic acid disrupts SARS-CoV-2 spike protein glycosylation and selectively impairs bind...
Coronavirus disease (COVID-19) - World Health Organization (WHO)
Coronavirus disease (COVID-19) World Health Organization (WHO)
SARS-CoV-2-derived RNA replicons as safe and effective vaccines - PNAS
SARS-CoV-2-derived RNA replicons as safe and effective vaccines PNAS
DNA origami vaccines could be the next leap beyond mRNA - ScienceDaily
DNA origami vaccines could be the next leap beyond mRNA ScienceDaily
Weekly respiratory virus update, week 10, March 2026 - European Centre for Disease Prevention and...
Weekly respiratory virus update, week 10, March 2026 European Centre for Disease Prevention and Control
Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants - Na...
Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants Nature
Long-COVID prevalence may vary by COVID-19 variant, time since infection - CIDRAP
Long-COVID prevalence may vary by COVID-19 variant, time since infection CIDRAP
Staying Up to Date with COVID-19 Vaccines - Centers for Disease Control and Prevention | CDC (.gov)
Staying Up to Date with COVID-19 Vaccines Centers for Disease Control and Prevention | CDC (.gov)
COVID-19 Jumped to Humans Without Prior Adaptation - respiratory-therapy.com
COVID-19 Jumped to Humans Without Prior Adaptation respiratory-therapy.com
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - Nature
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade Nature
Effect of the S2’ site cleavage on SARS-CoV-2 spike - Nature
Presence of SARS-CoV-2 in fetal organs via intraamniotic infection - Nature
Presence of SARS-CoV-2 in fetal organs via intraamniotic infection Nature
Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a ...
Anti-SARS-CoV-2 antibodies from severe COVID-19 individuals or S2 immunizations do not worsen dis...
Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron e...
The seven enigmas of SARS-CoV-2: From the past to the future - Rockefeller University Press
The seven enigmas of SARS-CoV-2: From the past to the future Rockefeller University Press
Tracing SARS-CoV-2 clusters across local scales using genomic data - PNAS
Tracing SARS-CoV-2 clusters across local scales using genomic data PNAS
Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of work...
Surveillance and Data Analytics | COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)
Surveillance and Data Analytics | COVID-19 Centers for Disease Control and Prevention | CDC (.gov)
SARS-CoV-2 nsp15 enhances viral virulence by subverting host antiviral defenses - PNAS
SARS-CoV-2 nsp15 enhances viral virulence by subverting host antiviral defenses PNAS
Genetic signatures in SARS-CoV-2 show no evidence of lab origin - 동아사이언스
Genetic signatures in SARS-CoV-2 show no evidence of lab origin 동아사이언스
Intranasal measles virus– and mumps virus–based SARS-CoV-2 vaccine candidates prevent SARS-CoV-2 ...
Case-based evidence links increased SARS-CoV-2 diversity to impaired IFN-I response in severe COV...
Case-based evidence links increased SARS-CoV-2 diversity to impaired IFN-I response in severe COVID-19 Rockefeller University Press
Severe COVID-19 and flu can facilitate lung cancer months or years later - Medical Xpress
Severe COVID-19 and flu can facilitate lung cancer months or years later Medical Xpress
SARS-CoV-2 Causes Buildup of Alzheimer’s-Related Peptides in the Retina - Yale School of Medicine
SARS-CoV-2 Causes Buildup of Alzheimer’s-Related Peptides in the Retina Yale School of Medicine
Scientists Get a Glimpse of How New Pandemics Are Made - The New York Times
Scientists Get a Glimpse of How New Pandemics Are Made The New York Times
The Virtual Lab of AI agents designs new SARS-CoV-2 nanobodies - Nature
The Virtual Lab of AI agents designs new SARS-CoV-2 nanobodies Nature
COVID-19: how worried should we be about the Frankenstein variant? | - Institut Pasteur
COVID-19: how worried should we be about the Frankenstein variant? | Institut Pasteur
WHO Scientific advisory group issues report on origins of COVID-19 - World Health Organization (WHO)
WHO Scientific advisory group issues report on origins of COVID-19 World Health Organization (WHO)
Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Bination...
Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study | Circulation American Heart Association Journals
Could this Molecule be ‘Checkmate’ for Coronaviruses like SARS-CoV-2? - UC San Francisco
Could this Molecule be ‘Checkmate’ for Coronaviruses like SARS-CoV-2? UC San Francisco
Age associated SARS-CoV-2 immune responses provide insights into population immunity over four ye...
Post-COVID Liver Complications Revealed - European Medical Journal
Post-COVID Liver Complications Revealed European Medical Journal
SARS-CoV-2 Vaccines and Multiple Sclerosis - Neurology® Journals
SARS-CoV-2 Vaccines and Multiple Sclerosis Neurology® Journals
National flu and COVID-19 surveillance report: 12 March 2026 (week 11) - GOV.UK
National flu and COVID-19 surveillance report: 12 March 2026 (week 11) GOV.UK
Gene Analysis Suggests COVID-19 Virus Emerged Naturally, Not From Lab - National Today
Gene Analysis Suggests COVID-19 Virus Emerged Naturally, Not From Lab National Today
SARS-CoV-2 spike protein: structure, viral entry and variants - Nature
SARS-CoV-2 spike protein: structure, viral entry and variants Nature
Scientists reveal how people who have had Covid-19 have increased risk of one type of cancer - UN...
Scientists reveal how people who have had Covid-19 have increased risk of one type of cancer UNILAD
Plea for renewed focus on Long COVID - HealthandCare.scot
Plea for renewed focus on Long COVID HealthandCare.scot
Coronavirus disease 2019 - Colorado Pols
Coronavirus disease 2019 Colorado Pols
READ: The Surprising Way Officials Want To Detect The Next Pandemic - facebook.com
READ: The Surprising Way Officials Want To Detect The Next Pandemic facebook.com
Outbreak Origins Unveiled by Zoonotic Virus Natural Selection - Genetic Engineering and Biotechno...
Outbreak Origins Unveiled by Zoonotic Virus Natural Selection Genetic Engineering and Biotechnology News
Most pandemic viruses jump to humans without prior adaptation: Study - Down To Earth
Most pandemic viruses jump to humans without prior adaptation: Study Down To Earth
Long-Term Neurodevelopment Effects of Antenatal COVID-19 - Bioengineer.org
Long-Term Neurodevelopment Effects of Antenatal COVID-19 Bioengineer.org
New study suggests true origins of Covid-19 might not be what we thought - UNILAD Tech
New study suggests true origins of Covid-19 might not be what we thought UNILAD Tech
Lab Leak: The True Origins of Covid-19 - The White House (.gov)
Lab Leak: The True Origins of Covid-19 The White House (.gov)
The proximal origin of SARS-CoV-2 - Nature
Tracking SARS-CoV-2 variants - World Health Organization (WHO)
Tracking SARS-CoV-2 variants World Health Organization (WHO)
Transmission of SARS-CoV-2: implications for infection prevention precautions - World Health Orga...
Transmission of SARS-CoV-2: implications for infection prevention precautions World Health Organization (WHO)
The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and nam...
SARS-CoV-2 in Animals - aphis.usda.gov
SARS-CoV-2 in Animals aphis.usda.gov
Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras - The New En...
Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras The New England Journal of Medicine
Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis - PNAS
Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis PNAS
Acute and postacute sequelae associated with SARS-CoV-2 reinfection - Nature
Acute and postacute sequelae associated with SARS-CoV-2 reinfection Nature
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics - Nature
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics Nature
Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern - World Health Organization ...
Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern World Health Organization (WHO)
Testing for COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)
Testing for COVID-19 Centers for Disease Control and Prevention | CDC (.gov)
SARS-CoV-2 infection and persistence in the human body and brain at autopsy - Nature
SARS-CoV-2 infection and persistence in the human body and brain at autopsy Nature
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) - Nature
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) Nature
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans - Nature
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans Nature
Long COVID after breakthrough SARS-CoV-2 infection - Nature
SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels - ...
SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels Nature
Animals and COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)
Animals and COVID-19 Centers for Disease Control and Prevention | CDC (.gov)
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion - Nature
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion Nature
Characteristics of SARS-CoV-2 and COVID-19 - Nature
Joint statement on the prioritization of monitoring SARS-CoV-2 infection in wildlife and preventi...
Joint statement on the prioritization of monitoring SARS-CoV-2 infection in wildlife and preventing the formation of animal reservoirs World Health Organization (WHO)
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 - The New England Journal...
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 The New England Journal of Medicine
The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2 - Science | AAAS
The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2 Science | AAAS
Antigen-detection in the diagnosis of SARS-CoV-2 infection - World Health Organization (WHO)
Antigen-detection in the diagnosis of SARS-CoV-2 infection World Health Organization (WHO)
Pre–Covid-19, SARS-CoV-2–Negative Multisystem Inflammatory Syndrome in Children - The New England...
Pre–Covid-19, SARS-CoV-2–Negative Multisystem Inflammatory Syndrome in Children The New England Journal of Medicine
SARS-CoV-2 Infection in Children - The New England Journal of Medicine
SARS-CoV-2 Infection in Children The New England Journal of Medicine
SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling - PNAS
SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling PNAS
Outbreak of SARS-CoV-2 Infections, including COVID-19 ... - Centers for Disease Control and Preve...
Outbreak of SARS-CoV-2 Infections, including COVID-19 ... Centers for Disease Control and Prevention | CDC (.gov)
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection - Nature
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection Nature
Widespread exposure to SARS-CoV-2 in wildlife communities - Nature
Widespread exposure to SARS-CoV-2 in wildlife communities Nature
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation - Nature
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation Nature
Activity of Research-Grade Pemivibart against Recent SARS-CoV-2 JN.1 Sublineages - The New Englan...
Activity of Research-Grade Pemivibart against Recent SARS-CoV-2 JN.1 Sublineages The New England Journal of Medicine
SARS-CoV-2 infection of the oral cavity and saliva - Nature
SARS-CoV-2 evolution during treatment of chronic infection - Nature
SARS-CoV-2 evolution during treatment of chronic infection Nature
SARS-CoV-2 Variant XEC Increases as KP.3.1.1 Slows - Centers for Disease Control and Prevention |...
SARS-CoV-2 Variant XEC Increases as KP.3.1.1 Slows Centers for Disease Control and Prevention | CDC (.gov)
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans - Nature
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans Nature
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | New England Journal of Medicine - The N...
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | New England Journal of Medicine The New England Journal of Medicine
Structural basis of SARS-CoV-2 polymerase inhibition by nonnucleoside inhibitor HeE1-2Tyr - PNAS
Structural basis of SARS-CoV-2 polymerase inhibition by nonnucleoside inhibitor HeE1-2Tyr PNAS
SARS-CoV-2 pathogenesis - Nature
SARS-CoV-2 pathogenesis Nature
SARS-CoV-2 fragments may cause problems after infection - National Institutes of Health (.gov)
SARS-CoV-2 fragments may cause problems after infection National Institutes of Health (.gov)
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults - Nature
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults Nature
Effect of Vaccination on Household Transmission of SARS-CoV-2 in England - The New England Journa...
Effect of Vaccination on Household Transmission of SARS-CoV-2 in England The New England Journal of Medicine
Detection of SARS-COV-2 variants and their proportions in wastewater samples using next-generatio...
SARS-CoV-2 Variants and Vaccines | New England Journal of Medicine - The New England Journal of M...
SARS-CoV-2 Variants and Vaccines | New England Journal of Medicine The New England Journal of Medicine
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity - Nature
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity Nature
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization - Nature
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization Nature